CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized vaccine trial offers new hope for advanced kidney cancer patients
Disease control Not yet recruitingThis is a very early study to check the safety and initial effects of a new personalized vaccine called KSD-201 for people with advanced kidney cancer that has stopped responding to standard treatments. Doctors will make the vaccine from the patient's own immune cells and give it…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: EARLY_PHASE1 • Sponsor: Kousai Bio Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New scan could spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThis study is testing whether a new type of PET scan using a special tracer called 89Zr-girentuximab can better detect leftover or returning kidney cancer after initial treatment. Researchers want to see if this scan is more accurate than current imaging methods at finding cancer…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Apr 04, 2026 05:21 UTC